Latest articles for Major Depressive Disorder
Feature
NIMH strategic plan returns balance to research priorities
The NIMH’s strategic plan renews and expands a focus on suicide prevention, early intervention in psychosis, and the needs of diverse populations...
Conference Coverage
Depression linked to neuro dysfunction, brain lesions in MS
“Depression isn’t just a neuropsychiatric disease,” said Dr. Jenny Feng.
From the Journals
Suicide attempts more common, more lethal, new U.S. data show
“Adolescents and older adults aged 65-74 years experienced general increases in suicide attempts by all means, including poisoning,” the...
Commentary
COVID-19: Loss and grief without an expiration date
The lack of certainty about when the losses caused by the pandemic will end makes it difficult to process and mourn appropriately, Dr. Dara...
From the Journals
Hormone therapy boosts body image in transgender youth
After a year, gender-affirming hormone therapy improved body satisfaction and mental health in adolescents.
Latest News
Expert: Eliminating HCV ‘sounds ambitious, but I think it’s possible’
An estimated one in three inmates in the United States has chronic HCV.
From the Journals
Novel analysis links insomnia to first-onset major depressive disorder
First-onset major depressive disorder was significantly associated with difficulty initiating sleep among individuals in a 6-year prospective...
FDA/CDC
FDA fast-tracks psilocybin for major depressive disorder
A nonprofit medical research organization has received a Breakthrough Therapy designation for the psychedelic drug.
Conference Coverage
Questions surround ‘exciting’ intranasal esketamine
SAN DIEGO – Depression drug’s ideal dosage, long-term effects are still uncertain.